326030.KS · Korea Exchange KOSPI Market
SK Biopharmaceuticals Co Ltd
Compare this company’s P/E and P/S using trailing results and the latest quarter. Ratios are calculated here from market capitalisation, signed ordinary or common-shareholder earnings and revenue.
Market cap US$4.46bnFinancials dated 30 June 2026Price dated 2 October 2026
Core valuation
Calculation inputs
- Trailing earnings
- US$292.31m
- Latest-quarter run-rate earnings
- US$248.06m
- Latest fiscal-year earnings
- US$194.61m
- Trailing revenue
- US$627.94m
- Latest-quarter run-rate revenue
- US$721.34m
- Latest fiscal-year revenue
- US$515.23m
Featured ETF and mutual-fund exposure
These public funds report this company in their latest disclosed holdings.
- EFFE · Harbor Osmosis Emerging Markets Resource Efficient ETF2.69% weight · Holdings dated 30 April 2026Holdings available · disclosure too old for reliabilityHoldings dated 30 April 2026 are 162 days old, beyond this source’s 155-day reliability limit. Ratios remain available as dated research; calculations are unchanged and are not labelled reliable.
- IBRN · iShares Neuroscience and Healthcare ETF2.33% weight · Holdings dated 21 August 2026
- FLKR · Franklin FTSE South Korea ETF0.11% weight · Holdings dated 30 June 2026
- EEMS · iShares MSCI Emerging Markets Small-Cap ETF0.10% weight · Holdings dated 21 August 2026
- DFSE · Dimensional Emerging Markets Sustainability Core 1 ETF0.06% weight · Holdings dated 30 April 2026Holdings available · disclosure too old for reliabilityHoldings dated 30 April 2026 are 162 days old, beyond this source’s 155-day reliability limit. Ratios remain available as dated research; calculations are unchanged and are not labelled reliable.
- DEHP · Dimensional Emerging Markets High Profitability ETF0.06% weight · Holdings dated 30 April 2026Holdings available · disclosure too old for reliabilityHoldings dated 30 April 2026 are 162 days old, beyond this source’s 155-day reliability limit. Ratios remain available as dated research; calculations are unchanged and are not labelled reliable.
- IDHQ · Invesco S&P International Developed Quality ETF0.03% weight · Holdings dated 30 April 2026Holdings available · disclosure too old for reliabilityHoldings dated 30 April 2026 are 162 days old, beyond this source’s 155-day reliability limit. Ratios remain available as dated research; calculations are unchanged and are not labelled reliable.
- DEXC · Dimensional Emerging Markets ex China Core Equity ETF0.03% weight · Holdings dated 30 April 2026Holdings available · disclosure too old for reliabilityHoldings dated 30 April 2026 are 162 days old, beyond this source’s 155-day reliability limit. Ratios remain available as dated research; calculations are unchanged and are not labelled reliable.
- VPL · Vanguard FTSE Pacific ETF0.02% weight · Holdings dated 31 August 2026
- XSOE · WisdomTree Emerging Markets ex-State-Owned Enterprises Fund0.02% weight · Holdings dated 30 June 2026
Sources and limitations
Financial inputs are attributed to OpenDART statutory filings. Market cap is calculated locally where auditable price and share inputs are available. Missing data stays missing; losses are retained as signed values and produce a numeric signed P/E.
Open financial sourceFinancials as of 30 June 2026. Informational research, not investment advice.